BPRN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy BPRN now: the chart is in a clean uptrend (SMA_5 > SMA_20 > SMA_200) with strengthening momentum (MACD histogram positive and expanding).", "Fundamentals just confirmed the trend: Q4 2025 showed strong YoY EPS (+20%) and net income growth (+16.3%) with improving asset quality (non-performing assets down).", "Near-term setup: pre-market price (37.84) is pushing above R1 (37.759); a continuation move targets R2 (38.337).", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Trend: Bullish structure with stacked moving averages (SMA_5 > SMA_20 > SMA_200), indicating a sustained uptrend.", "Momentum: MACD histogram at 0.0669 (above zero) and positively expanding, supporting upside continuation.", "RSI: RSI_6 at 65.67 (upper-neutral), showing strong demand but not yet an extreme overbought reading.", "Key levels: Pivot 36.823; Support S1 35.887 (then S2 35.309). Resistance R1 37.759 (being tested/breached pre-market) and R2 38.337 (next upside target).", "Tactical read: price is extended into resistance, but the momentum/trend profile favors a breakout attempt rather than immediate reversal."]
["Q4 2025 results: GAAP EPS $0.90 with strong profitability and revenue $20.74M (per news summary).", "Net income rose to $6.1M in Q4 2025 (+16.32% YoY), indicating improved earnings power.", "Non-interest income increased to $2.1M, supporting revenue diversification.", "Non-performing assets decreased to $16.5M, signaling improving credit quality.", "Stockholders' equity increased by $8.7M (+3.31%) as of Dec 31, 2025, strengthening the balance sheet."]
["Short-term technical positioning is near/just above resistance (R1), which can cap upside if follow-through buying is limited.", "Hedge fund and insider activity signals are neutral, implying no strong smart-money confirmation in the provided trend data.", "No valuation data provided, limiting conviction on whether the current price is cheap vs peers."]
["Latest quarter: 2025/Q4.", "Revenue: $18.36M, +1.89% YoY (modest top-line growth).", "Net income: $6.08M, +16.32% YoY (profit growth outpacing revenue).", "EPS: $0.90, +20.00% YoY (strong per-share earnings growth).", "Balance sheet/credit tone (from news): equity up +3.31% and non-performing assets down, supportive for a bank\u2019s risk profile."]
["No analyst rating or price target change data was provided in the dataset.", "Wall Street pro/con view cannot be fully assessed from the provided inputs; based on the available fundamentals and trend, the case is pro-growth/profitability with the main con being limited visibility on valuation and external analyst conviction.", "Politicians / influential figures: No recent congress trading data available (no evidence of recent political buying/selling in the last 90 days)."]
